Clinical Trial Update: PAR I - Patient-to-Annulus Relation I

View source ↗

Summary

Abbott Medical Devices reports completion of the PAR I trial evaluating patient-to-annulus relation in aortic valve disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Snippet

Sponsor: Abbott Medical Devices | Conditions: Aortic Valve Disease | Status: COMPLETED